Published in AIDS Weekly, September 20th, 2010
"The opposing argument is that protection from superinfection is significant, reflecting a robust immune response that might be harnessed by...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2010-09-20)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.